Nieoullon, André

Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine*. [electronic resource] - Current medical research and opinion Dec 2008 - 3357-67 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1473-4877

10.1185/03007990802522397 doi


Acetylcholine--metabolism
Activity Cycles--drug effects
Aging--metabolism
Alzheimer Disease--drug therapy
Cholinesterase Inhibitors--adverse effects
Female
Galantamine--adverse effects
Humans
Male
Memory--drug effects
Sleep Stages--drug effects